Stensman Helena, Larsson Christer
Lund University, Center for Molecular Pathology, Dept of Laboratory Medicine, Malmö University Hospital, Malmö, Sweden.
BMC Cancer. 2008 Dec 11;8:365. doi: 10.1186/1471-2407-8-365.
Migration is important for the metastatic capacity and thus for the malignancy of cancer cells. There is limited knowledge on regulatory factors that promote the migration of neuroblastoma cells. This study investigates the hypothesis that protein kinase C (PKC) isoforms regulate neuroblastoma cell motility.
PKC isoforms were downregulated with siRNA or modulated with activators and inhibitors. Migration was analyzed with scratch and transwell assays. Protein phosphorylation and expression levels were measured with Western blot.
Stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) induced migration of SK-N-BE(2)C neuroblastoma cells. Treatment with the general protein kinase C (PKC) inhibitor GF109203X and the inhibitor of classical isoforms Gö6976 inhibited migration while an inhibitor of PKCbeta isoforms did not have an effect. Downregulation of PKCepsilon, but not of PKCalpha or PKCdelta, with siRNA led to a suppression of both basal and TPA-stimulated migration. Experiments using PD98059 and LY294002, inhibitors of the Erk and phosphatidylinositol 3-kinase (PI3K) pathways, respectively, showed that PI3K is not necessary for TPA-induced migration. The Erk pathway might be involved in TPA-induced migration but not in migration driven by PKCepsilon. TPA induced phosphorylation of the PKC substrate myristoylated alanine-rich C kinase substrate (MARCKS) which was suppressed by the PKC inhibitors. Treatment with siRNA oligonucleotides against different PKC isoforms before stimulation with TPA did not influence the phosphorylation of MARCKS.
PKCepsilon is important for migration of SK-N-BE(2)C neuroblastoma cells. Neither the Erk pathway nor MARCKS are critical downstream targets of PKCepsilon but they may be involved in TPA-mediated migration.
迁移对于癌细胞的转移能力至关重要,因此对于癌细胞的恶性程度也很重要。关于促进神经母细胞瘤细胞迁移的调控因子的了解有限。本研究调查了蛋白激酶C(PKC)同工型调节神经母细胞瘤细胞运动性的假说。
用小干扰RNA(siRNA)下调PKC同工型,或用激活剂和抑制剂进行调节。用划痕试验和Transwell试验分析迁移情况。用蛋白质印迹法测定蛋白质磷酸化和表达水平。
用12 - O - 十四酰佛波醇 - 13 - 乙酸酯(TPA)刺激可诱导SK - N - BE(2)C神经母细胞瘤细胞迁移。用通用蛋白激酶C(PKC)抑制剂GF109203X和经典同工型抑制剂Gö6976处理可抑制迁移,而PKCβ同工型抑制剂则无作用。用siRNA下调PKCε而非PKCα或PKCδ可导致基础迁移和TPA刺激的迁移均受到抑制。分别使用细胞外信号调节激酶(Erk)途径抑制剂PD98059和磷脂酰肌醇3 - 激酶(PI3K)途径抑制剂LY294002进行的实验表明,PI3K对于TPA诱导的迁移不是必需的。Erk途径可能参与TPA诱导的迁移,但不参与由PKCε驱动的迁移。TPA诱导PKC底物富含肉豆蔻酰化丙氨酸的C激酶底物(MARCKS)的磷酸化,这被PKC抑制剂所抑制。在用TPA刺激之前用针对不同PKC同工型的siRNA寡核苷酸处理并不影响MARCKS的磷酸化。
PKCε对于SK - N - BE(2)C神经母细胞瘤细胞的迁移很重要。Erk途径和MARCKS都不是PKCε的关键下游靶点,但它们可能参与TPA介导的迁移。